Office:
7-176 Weaver-Densford Hall

E-mail Address:
stpet002@umn.edu

 

 

 

 

 

 

 

 

 

Dr. St. Peter is currently Professor with the Department of Pharmaceutical Care and Health Systems. St. Peter received her B.S. degree in Pharmacy from the University of Montana in 1983 and the Doctor of Pharmacy degree from the University of Texas Health Science Center at San Antonio and UT Austin in 1986, where she also completed a fellowship in adult medicine in 1988. She has been on faculty with the College of Pharmacy since 1988. Dr. St. Peter was involved in nephrology as a clinical practitioner from 1988 to 1996 at Hennepin County Medical Center in Minneapolis, Minnesota and obtained Board Certification in Pharmacotherapy in 1991. St.

 

Peter provided an active consult service in the medication management of dialysis patients in both the inpatient and ambulatory settings.

In 1996 St. Peter accepted a new position at the College as the Associate Dean of Professional Education. In her role as Associate Dean she managed the Office of Student Services and provided over site of the traditional Pharm.D. program. In January 2000, St. Peter stepped down from the Associate Dean's position to more fully pursue her research interests in nephrology.

 

She is currently involved in pharmacoepidemiologic research involving Medicare and other large patient databases with the Chronic Disease Research Group and the United States Renal Data System Coordinating Center at Hennepin County Medical Center in Minneapolis. She has served a term on the Editorial Board of the Pharmacotherapy Self-Assessment Program (PSAP) and was also a preceptor for the ASHP Clinical Dialysis Traineeship Program. She was appointed to the Minnesota Department of Human Services Drug Utilization Review Board from 2000-2006. St. Peter served as a Technical Expert Panel (TEP) member for Center for Medicare and Medicaid Services (CMS) for the End-Stage Renal Disease (ESRD) Outpatient Medications Project and is currently on the CMS Technical Expert Panel (TEP) for CKD/ESRD Medication Measures Project. She provides her expertise to the National Kidney Foundation (NKF) Kidney Medicare Drugs Awareness and Education Initiative to help address the complexity of Medicare Part D.

 

St. Peter’s research revolves around the evaluation of medication utilization and medication adherence on medical and economic outcomes in chronic kidney disease patients.

 

Phar 6121: Pharmacotherapy I (instructor)

 

Kausz A, Solid C, Pereira BJG, Collins AJ, St. Peter WL. Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease? Am J Kidney Dis 2005;45(1):136-147.

 

Collins AJ, Kasiske B, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, Matas A, McBean M, Murray A, St. Peter W, Xue J, et al. Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 2005;45(Suppl 1):v-vii, S1-S280.

 

St. Peter WL, Obrador GT, Roberts TL, Collins AJ. Trends in intravenous iron use among dialysis patients in the United States (1994-2002). Am J Kidney Dis 2005;46(4):650-660.

 

Manley HJ, Cannella CA, Bailie GR, St. Peter WL. Medication-related problems in ambulatory hemodialysis patients: a pooled analysis. Am J Kidney Dis 2005;46(4):669-680.

 

Collins AJ, Kasiske B, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, Matas A, McBean M, Murray A, St. Peter W, Xue J, et al. Excerpts from the United States Renal Data System 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 2006;47(Suppl 1):v-vi, S1-S286.

 

Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, McBean M, Murray A, St. Peter W, Xue J, et al. Excerpts from the United States Renal Data System 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 2007;49(Suppl 1):vi-vii, S1-S296.

 

Ye X, Gross CR, Schommer J, Cline R, Xuan J, St. Peter WL. Initiation of statins after hospitalization for coronary heart disease. J Manag Care Pharm 2007;13(5):385-396.

 

Ye X, Gross CR, Schommer J, Cline R, St. Peter WL. Association between copayment and adherence to statin teatment after coronary heart disease hospitalization; a longitudinal, retrospective, cohort study. Clin Ther 2007;29(12):2748-2757.

 

St. Peter WL. Introduction: chronic kidney disease: a burgeoning health epidemic. J Manag Care Pharm 2007;13(9 Suppl D):S2-S5.

 

St. Peter WL. Chronic kidney disease and Medicare. J Manag Care Pharm 2007;13(9 Suppl D):S13-S18.

 

Collins AJ, Foley R, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Zhang R, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L. Excerpts from the United States Renal Data System 2007 Annual Data Report. Am J Kidney Dis. 2008 Jan;51(1 Suppl 1):S1-320. 

 

St. Peter WL, Liu J, Weinhandl E, Fan Q. A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data. Am J Kidney Dis 2008;51(3):445-454.

St. Peter WL. Potential impact of Medicare Part D in the end-stage renal disease population. Adv Chronic Kidney Dis 2008;15(2):140-146.

14. St. Peter WL, Weinhandl ED, Liu J. Vitamin D use and mortality in chronic kidney disease: immortal time bias. Arch Intern Med 2008;168(21):2384-2385.

 

St. Peter WL, Liu J, Weinhandl E, Fan Q. Linking Centers for Medicare & Medicaid Services data with prospective DCOR trial data: methods and data comparison results. Hemodial Int 2008; 12(4):480-491.

 

Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St. Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R,

Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L. United States Renal Data System 2008 Annual Data Report Abstract. Am J Kidney Dis. 2009 Jan;53(1 Suppl):vi-vii, S8-374.

 

St. Peter WL, Li S, Liu J, Gilbertson D, Arneson T, Collins AJ. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis. Pharmacotherapy 2009;29(2):154-164.

 

St. Peter WL, Li Q, Liu J, Persky M, Nieman K, Arko C, Block GA. Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006. Clin J Am Soc Nephrol 2009;4(2):354-360.